Drug Manufacturing

Active Pharmaceutical Ingredients Tariffs Weight Loss Drugs Supply Chain U.S. Drug Policy Research and Development Regulatory Issues Sales Performance Market Trends Drug Investment Chemical Sourcing Gene Therapy Trade Policies Supply Chain Management Active Ingredients

4 ARTICLES

last mo.

Pharmaceutical Giants Grapple With Tariff Uncertainty as Roche Seeks Exemptions

Roche leads negotiations with the Trump administration while drugmakers shift production, build inventories, and pledge major U.S. investments to mitigate potential impacts.

16 ARTICLES

2mo ago

Roche Announces $50 Billion U.S. Investment to Expand Manufacturing and R&D

8 ARTICLES

3mo ago

Johnson & Johnson Launches $55 Billion U.S. Manufacturing and Research Expansion

15 ARTICLES

3mo ago

Eli Lilly Invests $9 Billion to Boost Production of Weight Loss Drugs

Drug Manufacturing

Pharmaceutical Giants Grapple With Tariff Uncertainty as Roche Seeks Exemptions

Roche Announces $50 Billion U.S. Investment to Expand Manufacturing and R&D

Johnson & Johnson Launches $55 Billion U.S. Manufacturing and Research Expansion

Eli Lilly Announces $27 Billion Investment in U.S. Manufacturing Expansion

Johnson & Johnson Exceeds Q4 Expectations with Strong Cancer Drug Sales

Eli Lilly Names Lucas Montarce as New CFO Amid Expansion Efforts

Eli Lilly Invests $9 Billion to Boost Production of Weight Loss Drugs